Authors

Caron Jacobson, MD, Harvard Medical School

Latest:

Dr. Langstraat on Sentinel Lymph Nodes for Endometrial Cancer

Carrie L. Langstraat, MD, gynecologic oncologist, Mayo Clinic, discusses the role of sentinel lymph nodes in patients with endometrial cancers.

Carrie Stricker, PhD, RN

Latest:

Carrie Stricker on the Efficacy of Survivorship Care Plans

Carrie Stricker from the Abramson Cancer Center of the University of Pennsylvania on the Efficacy of Survivorship Care Plans for Posttreatment Breast Cancer Survivors.

Carryn Anderson, MD

Latest:

Dr. Anderson on Superoxide Dismutase Mimetic GC4419 in Treating Patients With Oropharyngeal Carcinoma

Carryn Anderson, MD, assistant professor of Radiation Oncology, University of Iowa, discusses a phase Ib/IIa study of superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavitiy or oropharyngeal carcinoma.

Cary Presant, MD, FACP, FASCO

Latest:

Dr. Presant on Adjusting Clinical Trials to Value-Based Care

Cary Presant, MD, FACP, FASCO, City of Hope Medical Center, discusses clinical trials and value-based care.

Casey Cosgrove, MD

Latest:

Dr Cosgrove on the Evolution of ADC Treatment in Ovarian Cancer

Casey M. Cosgrove, MD, discusses the evolution of treatment with antibody-drug conjugates for patients with ovarian cancer.

Casey M. Cosgrove, MD

Latest:

Dr. Cosgrove on Utilizing Biomarker-Informed Treatments Endometrial Cancer

Casey M. Cosgrove, MD, discusses utilizing biomarker-informed treatments in endometrial cancer.

Casey Moffa, DO

Latest:

How to Perform the Perfect Bone Marrow Biopsy

Obtaining a high-quality bone marrow aspirate and biopsy is very important for the patientâ€”and for you. Following these general guidelines will help you do this successfully.

Catherine Bollard, MD

Latest:

Dr. Bollard on the Treatment of EBV-Positive Lymphoma

Catherine Bollard, MBChB, MD, Professor of Pediatrics, Medicine, and Pathology & Immunology, Baylor College of Medicine, discusses the treatment of EBV-positive lymphoma with T-cell therapy.

Catherine Frenette, MD, FAST, AGAF, Scripps MD Anderson Cancer Center

Catherine Frenette, MD, Scripps Green Hospital

Catherine Lyons, RN, MS

Latest:

Merging Community Practices With an Academic Cancer Center

Consolidation of community oncology practices with hospital-based cancer centers is an accelerating trend that will affect future healthcare delivery models. This year, the Community Oncology Alliance reported hospital acquisitions and corporate mergers among 55% of 1338 community oncology practices surveyed, representing a 20% increase over the previous year's results.

Catherine M. Diefenbach, MD

Latest:

Dr. Diefenbach on Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in FL

Catherine M. Diefenbach, MD, discusses polatuzumab vedotin (Polivy) plus obinutuzumab (Gazyva) and lenalidomide (Revlimid) in patients with follicular lymphoma.

Catherine Pietanza, MD

Latest:

Dr. Pietanza on Rova-T for Small Cell Lung Cancer

Catherine Pietanza, MD, assistant attending physician at Memorial Sloan Kettering Cancer Center, discusses novel targeted therapy rovalpituzumab tesirine (Rova-T), which showed activity in relapsed and refractory small cell lung cancer (SCLC) in a recent phase I study.

Catherine Smith, MD

Latest:

Dr. Smith on Acquired Resistance to Targeted Agents for AML

Catherine Smith, MD, assistant professor, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, discusses patient acquired resistance in quizartinib (AC220) and gilteritinib (ASP2215) in acute myeloid leukemia (AML).

Catherine T. Frenette, MD, MD Anderson Cancer Center

Catherine T. Frenette, MD, Scripps Green Hospital

Catherine Tsien Swick

Latest:

More Effort Needed to Understand Value Breadth of Molecular Testing

As the use of testing increases, so does the importance of understanding exactly what it can do for your patients and how to get the most out of the results.

Cathy Bealer, RN, MHA

Latest:

How Does IT Affect Quality of Care?

Oncology practices across the country are using computer technology to improve outcomes and quality of care for our patients.

Cathy Eng, MD

Latest:

Dr. Eng on the Rationale for Studying the Impact of RAS Mutations in Early Onset Resectable CRC

Cathy Eng, MD, FACP, FASCO, discusses the rationale for studying the impact of RAS mutations in patients with early onset resectable colorectal cancer.